Dr Rahul Bhargava

MBBS, MD, DM (Clinical Haematology)

Principal Director & Chief Hematology at Fortis Hospital

MBBS, MD, DM (Clinical Haematology)

Principal Director & Chief Hematology at Fortis Hospital

B-cell Lymphoma

Contact Us

Related Videos :

Frequently Asked Questions (FAQ) :

Survival rates depend on the type and stage of lymphoma. For DLBCL, the 5-year survival rate is around 60-70% with appropriate treatment.

Yes, many types of B-cell lymphoma are curable, especially when diagnosed early and treated with the right combination of therapies.

The duration of treatment varies. Chemotherapy cycles often last 3-6 months, while more aggressive treatments or transplants may take longer.

Success rates depend on factors like the patient’s age, health, and response to previous treatments. For many patients, the success rate of bone marrow transplants is between 50-70%.

B-cell Lymphoma Treatment in India by Dr. Rahul Bhargava

Dr. Rahul Bhargava, a renowned hematologist and bone marrow transplant expert in India, provides advanced treatments for B-cell lymphoma, offering world-class care with a patient-centered approach.

What is B-cell Lymphoma?

B-cell lymphoma is a type of non-Hodgkin lymphoma (NHL) that affects the B-cells, a crucial part of the body’s immune system responsible for producing antibodies to fight infections. This disease can manifest in various forms, ranging from slow-growing (indolent) to fast-growing (aggressive) types.

Causes of B-cell Lymphoma

While the exact cause of B-cell lymphoma is not always clear, several factors can increase the risk:

  1. Age: Most cases are diagnosed in people aged 60 and older.
  2. Weakened immune system: Those with a compromised immune system (e.g., due to HIV/AIDS, autoimmune diseases) are more prone to developing lymphoma.
  3. Viral and bacterial infections: Infections like Epstein-Barr Virus (EBV) or Helicobacter pylori can raise the risk of lymphoma.
  4. Genetic factors: Some genetic mutations can predispose individuals to B-cell lymphoma.

Environmental exposure: Contact with certain chemicals, such as pesticides or herbicides, may also elevate the risk.

Types of B-cell Lymphoma

B-cell lymphoma includes various subtypes, each with distinct characteristics. The most common types include:

  1. Diffuse large B-cell lymphoma (DLBCL): The most common and aggressive form of B-cell lymphoma.
  2. Follicular lymphoma: A slower-growing type, often less aggressive.
  3. Mantle cell lymphoma: A rare, aggressive form.
  4. Burkitt lymphoma: A highly aggressive lymphoma more commonly seen in children but can occur in adults.
  5. Small lymphocytic lymphoma (SLL): Often similar to chronic lymphocytic leukemia, this is a slow-growing form of lymphoma.

Symptoms of B-cell Lymphoma

Symptoms of B-cell lymphoma can vary depending on the subtype but often include:

  • Swollen lymph nodes (in the neck, armpits, or groin)
  • Unexplained weight loss
  • Night sweats
  • Fever
  • Fatigue
  • Shortness of breath or chest pain
  • Loss of appetite
  • Itchy skin or rashes
  • Abdominal pain or swelling

If you experience any of these symptoms, it’s important to seek medical attention for a proper diagnosis.

Diagnosis of B-cell Lymphoma

Accurate diagnosis is essential to determine the specific type of lymphoma and plan the most effective treatment. Dr. Rahul Bhargava uses the following diagnostic methods:

  1. Physical examination: To check for swollen lymph nodes or other abnormalities.
  2. Biopsy: A sample of the affected tissue (lymph node) is removed and analyzed to confirm lymphoma.
  3. Blood tests: To assess overall health and detect abnormalities.
  4. Imaging tests: Such as CT scans, PET scans, and MRI to determine the spread of lymphoma.
  5. Bone marrow biopsy: To check if lymphoma has spread to the bone marrow.

Treatment Options for B-cell Lymphoma

Treatment for B-cell lymphoma varies depending on the type, stage, and overall health of the patient. Dr. Rahul Bhargava offers personalized treatment plans, which may include:

  1. Chemotherapy: The use of anti-cancer drugs to kill lymphoma cells.
  2. Immunotherapy: Medications that help the immune system recognize and attack lymphoma cells.
    • Monoclonal antibodies like Rituximab are commonly used.
  3. Targeted therapy: Drugs that specifically target cancer cells without harming normal cells.
  4. Radiation therapy: Used in certain cases, especially when lymphoma is localized.
  5. Bone marrow transplant: For patients with aggressive or recurrent lymphoma, a bone marrow or stem cell transplant may be recommended.
  6. CAR-T cell therapy: A cutting-edge immunotherapy that reprograms the patient’s T cells to attack cancer cells.
  7. Clinical trials: Dr. Bhargava may also recommend participation in clinical trials to access newer therapies.

Cost of Treatment and Stay in India

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

×